Close Menu

Micronics

The test is Micronics’ first to receive FDA clearance, and the company is pursuing CE marking for it and the PanNAT system.

Brainco Biopharma has been awarded

Researchers from Seattle Children's Hospital, working with Sony subsidiary Micronics, are developing a point-of-care diagnostic to identify and track new influenza strains under a five-year, $5.3 million grant from the National Institute of Allergy and Infectious Diseases.

Micronics (Sony) has been awarded US Patent No. 8,431,389, "Portable high-gain fluorescence detection system."
Frederick Battrell and Troy Daiber are named as inventors.

Saint Louis University has received US Patent No. 8,431,388, "Three-component biosensors for detecting macromolecules and other analytes." According to the patent, the molecular biosensor generally consists of two epitope-binding agents and an oligonucleotide construct.

Roche Molecular Systems has been awarded US Patent No. 8,329,884, "Reagents and methods for detecting Neisseria gonorrhoeae."
Diane Kawa, Shi-Da Lu, and Peter Dailey are named as inventors.

Ventana Medical Systems, a member of the Roche Group, has received US Patent No.

Samsung Electronics has been awarded US Patent No.

Roche has been awarded US Patent No. 8,219,366, "Determination of elbow values for PCR for parabolic shaped curves;" and US Patent No. 8,219,324, "Real-time PCR elbow calling by equationless algorithm."

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.